Epidemiology and risk factors for IBD

Nature Reviews Gastroenterology and Hepatology

Volumn 12, Issue 4, 2015, Pages 205-217

  Ananthakrishnan, Ashwin N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; BIOLOGICAL PRODUCT; COLECALCIFEROL; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; IRON; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; ORAL CONTRACEPTIVE AGENT; PLACEBO; STEROID; VITAMIN D; ZINC;

APPENDECTOMY; BIOLOGICAL THERAPY; COUNSELING; CROHN DISEASE; DIET THERAPY; DIETARY FIBER; ENTERIC FEEDING; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; EXERCISE; FAT INTAKE; GASTROINTESTINAL SURGERY; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; HELP SEEKING BEHAVIOR; HIGH RISK POPULATION; HUMAN; HYGIENE; INCIDENCE; INFECTION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE FLORA; LIFESTYLE; MIGRATION; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SLEEP; SMOKING; SMOKING CESSATION; STRESS; STRESS MANAGEMENT; TREND STUDY; TWIN CONCORDANCE; ULCERATIVE COLITIS; URBAN RURAL DIFFERENCE; VEGETARIAN DIET; COLITIS, ULCERATIVE; FEMALE; HEALTH; MALE; STATISTICS AND NUMERICAL DATA;

COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GLOBAL HEALTH; HUMANS; INCIDENCE; MALE; PREVALENCE; RISK FACTORS;

EID: 84926416641     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2015.34     Document Type: Review

References (207)

1. Cosnes J., et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140, 1785-1794 (2011
2. Loftus E. V. Jr Clinical epidemiology of inflammatory bowel disease: incidence prevalence and environmental influences. Gastroenterology 126, 1504-1517 (2004
3. Abraham C. & Cho J. H. Inflammatory bowel disease. N. Engl. J. Med. 361, 2066-2078 (2009
4. Molodecky N. A., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time based on systematic review. Gastroenterology 142, 46-54.e42 (2012
5. Hugot J. P., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001
6. Ogura Y., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001
7. Jostins L., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012
8. Loftus E. V. Jr., et al. Ulcerative colitis in Olmsted County Minnesota 1940-1993: incidence prevalence and survival. Gut 46, 336-343 (2000
9. Loftus E. V. Jr., et al. Crohn's disease in Olmsted County Minnesota 1940-1993: incidence prevalence and survival. Gastroenterology 114, 1161-1168 (1998
10. Loftus C. G., et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County Minnesota 1940-2000. Inflamm. Bowel Dis. 13, 254-261 (2007
11. Nerich V., et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm. Bowel Dis. 12, 218-226 (2006
12. Khalili H., et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 61, 1686-1692 (2012
13. Gearry R. B., et al. High incidence of Crohn's disease in Canterbury New Zealand: results of an epidemiologic study. Inflamm. Bowel Dis. 12, 936-943 (2006
14. Bernstein C. N., et al. Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts. Can. J. Gastroenterol. 25, 269-273 (2011
15. Odes H. S., et al. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features. Gut 32, 1024-1026 (1991
16. Bernstein C. N., et al. A population-based case control study of potential risk factors for IBD. Am. J. Gastroenterol. 101, 993-1002 (2006
17. Mahid S. S., et al. Inflammatory bowel disease and African Americans: a systematic review. Inflamm. Bowel Dis. 14, 960-967 (2008
18. Reddy S. I. & Burakoff R. Inflammatory bowel disease in African Americans. Inflamm. Bowel Dis. 9, 380-385 (2003
19. Thia K. T., et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am. J. Gastroenterol. 103, 3167-3182 (2008
20. Ng S. C., et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and colitis epidemiology study. Gastroenterology 145, 158-165.e2 (2013
21. Archampong T. N. & Nkrumah K. N. Inflammatory bowel disease in Accra: what new trends. West Afr. J. Med. 32, 40-44 (2013
22. Ukwenya A. Y., et al. Inflammatory bowel disease in Nigerians: still a rare diagnosis?. Ann. Afr. Med. 10, 175-179 (2011
23. Al-Mofarreh M. A. & Al-Mofleh I. A. Emerging inflammatory bowel disease in Saudi outpatients: a report of 693 cases. Saudi J. Gastroenterol. 19, 16-22 (2013
24. Sood A. & Midha V. Epidemiology of inflammatory bowel disease in Asia. Indian J. Gastroenterol. 26, 285-289 (2007
25. Probert C. S., et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 33, 687-693 (1992
26. Probert C. S., et al. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 34, 1547-1551 (1993
27. Li X., et al. Risk of inflammatory bowel disease in first- and second-generation immigrants in Sweden: a nationwide follow-up study. Inflamm. Bowel Dis. 17, 1784-1791 (2011
28. Pinsk V., et al. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am. J. Gastroenterol. 102, 1077-1083 (2007
29. Benchimol E. I., et al. O 004 Inflammatory Bowel Disease in Immigrants to Canada and their Children: a Population-Based Cohort Study. Inflamm. Bowel Dis. 20 (Suppl. 1) S3-S4 (2014
30. Damas O. M., et al. Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study. Am. J. Gastroenterol. 108, 231-239 (2013
31. Halme L., et al. Family and twin studies in inflammatory bowel disease. World J. Gastroenterol. 12, 3668-3672 (2006
32. Khor B., Gardet A. & Xavier R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317 (2011
33. Liu J. Z. & Anderson C. A. Genetic studies of Crohn's disease: past present and future. Best Pract. Res. Clin. Gastroenterol. 28, 373-386 (2014
34. Orholm M., et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand. J. Gastroenterol. 35, 1075-1081 (2000
35. Russell R. K. & Satsangi J. IBD: a family affair. Best Pract. Res. Clin. Gastroenterol. 18, 525-539 (2004
36. Thompson N. P., et al. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 312, 95-96 (1996
37. Tysk C., et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29, 990-996 (1988
38. Yang H., et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 34, 517-524 (1993
39. Halfvarson J., et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124, 1767-1773 (2003
40. Hugot J. P., et al. Mapping a susceptibility locus for Crohn's disease on chromosome 16. Nature 29, 821-823 (1996
41. Jostins L., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012
42. VanDussen K. L., et al. Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease. Gastroenterology 146, 200-209 (2014
43. Van Limbergen J., Radford-Smith G. & Satsangi J. Advances in IBD genetics. Nat. Rev. Gastroenterol. Hepatol. 11, 372-385 (2014
44. Glocker E. O., et al. Inflammatory bowel disease and mutations affecting the interleukin 10 receptor. N. Engl. J. Med. 361, 2033-2045 (2009
45. Gevers D., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392 (2014
46. Kostic A. D., Xavier R. J. & Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146, 1489-1499 (2014
47. Morgan X. C., et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012
48. Nagalingam N. A. & Lynch S. V. Role of the microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 18, 968-984 (2012
49. Manichanh C., et al. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9, 599-608 (2012
50. Castiglione F., et al. Risk factors for inflammatory bowel diseases according to the hygiene hypothesis: a case-control multi-centre prospective study in Southern Italy. J. Crohns Colitis 6, 324-329 (2012
51. Ng S. C., et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut http://dx.doi.org/10.1136/gutjnl-2014-307410
52. Timm S., et al. Place of upbringing in early childhood as related to inflammatory bowel diseases in adulthood: a population-based cohort study in Northern Europe. Eur. J. Epidemiol. 29, 429-437 (2014
53. Willing B. P., et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844-1854.e1 (2010
54. Lepage P., et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141, 227-236 (2011
55. Darfeuille-Michaud A., et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412-421 (2004
56. Martin R., et al. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm. Bowel Dis. 20, 417-430 (2014
57. Sokol H., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731-16736 (2008
58. Sokol H., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15, 1183-1189 (2009
59. Wu G. D., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105-108 (2011
60. David L. A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014
61. Norman J. M., et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447-460 (2015
62. Iliev I. D., et al. Interaction between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 8, 1314-1347 (2012
63. Harries A. D., Baird A. & Rhodes J. Non-smoking: a feature of ulcerative colitis. Br. Med. J. (Clin. Res. Ed.) 284, 706 (1982
64. Mahid S. S., et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin. Proc. 81, 1462-1471 (2006
65. Higuchi L. M., et al. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am. J. Gastroenterol. 107, 1399-1406 (2012
66. Mahid S. S., et al. Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm. Bowel Dis. 13, 431-438 (2007
67. Odes H. S., et al. Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig. Dis. Sci. 46, 1717-1721 (2001
68. Cosnes J., et al. Gender differences in the response of colitis to smoking. Clin. Gastroenterol. Hepatol. 2, 41-48 (2004
69. Cosnes J. What is the link between the use of tobacco and IBD?. Inflamm. Bowel Dis. 14 (Suppl. 2) S14-S15 (2008
70. Cosnes J., et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 110, 424-431 (1996
71. Cosnes J., et al. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment. Pharmacol. Ther. 13, 1403-1411 (1999
72. Lakatos P. L., Szamosi T. & Lakatos L. Smoking in inflammatory bowel diseases: good bad or ugly?. World J. Gastroenterol. 13, 6134-6139 (2007
73. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract. Res. Clin. Gastroenterol. 18, 481-496 (2004
74. Birrenbach T. & Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology pathophysiology and therapeutic implications. Inflamm. Bowel Dis. 10, 848-859 (2004
75. Persson P. G., Hellers G. & Ahlbom A. Use of oral moist snuff and inflammatory bowel disease. Int. J. Epidemiol. 22, 1101-1103 (1993
76. Hatoum O. A., Heidemann J. & Binion D. G. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease. Ann. NY Acad. Sci. 1072, 78-97 (2006
77. McGilligan V. E., et al. Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. Inflamm. Bowel Dis. 13, 108-115 (2007
78. Bergeron V., et al. Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease. Inflamm. Bowel Dis. 18, 1101-1111 (2012
79. Ananthakrishnan A. N., et al. Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. Inflamm. Bowel Dis. 20, 783-789 (2014
80. Biedermann L., et al. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm. Bowel Dis. 20, 1496-1501 (2014
81. Munyaka P. M., Khafipour E. & Ghia J. E. External influence of early childhood establishment of gut microbiota and subsequent health implications. Front. Pediatr. 2, 109 (2014
82. Parkes G. C., Whelan K. & Lindsay J. O. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J. Crohns Colitis 8, 717-725 (2014
83. Andersson R. E., et al. Appendectomy and protection against ulcerative colitis. N. Engl. J. Med. 344, 808-814 (2001
84. Andersson R. E., et al. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 124, 40-46 (2003
85. Kaplan G. G., et al. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am. J. Gastroenterol. 103, 2925-2931 (2008
86. Cosnes J., et al. Prior appendectomy and the phenotype and course of Crohn's disease. World J. Gastroenterol. 12, 1235-1242 (2006
87. Gardenbroek T. J., et al. The effect of appendectomy on the course of ulcerative colitis: a systematic review. Colorectal Dis. 14, 545-553 (2012
88. Radford-Smith G. L. What is the importance of appendectomy in the natural history of IBD?. Inflamm. Bowel Dis. 14 (Suppl. 2), S72-S74 (2008
89. Radford-Smith G. L., et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 51, 808-813 (2002
90. Strachan D. P. Hay fever hygiene and household size. BMJ 299, 1259-1260 (1989
91. Radon K., et al. Contact with farm animals in early life and juvenile inflammatory bowel disease: a case-control study. Pediatrics 120, 354-361 (2007
92. Van Kruiningen H. J., et al. Environmental factors in familial Crohn's disease in Belgium. Inflamm. Bowel Dis. 11, 360-365 (2005
93. Barclay A. R., et al. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J. Pediatr. 155, 421-426 (2009
94. Bager P., et al. Cesarean section and offspring's risk of inflammatory bowel disease: a national cohort study. Inflamm. Bowel Dis. 18, 857-862 (2012
95. Sood A., et al. Low hygiene and exposure to infections may be associated with increased risk for ulcerative colitis in a North Indian population. Ann. Gastroenterol. 27, 219-223 (2014
96. Bernstein C. N., et al. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 42, 1129-1135 (2004
97. Chacon O., Bermudez L. E. & Barletta R. G. Johne's disease inflammatory bowel disease and Mycobacterium paratuberculosis. Annu. Rev. Microbiol. 58, 329-363 (2004
98. Feller M., et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect. Dis. 7, 607-613 (2007
99. Selby W., et al. Two-year combination antibiotic therapy with clarithromycin rifabutin and clofazimine for Crohn's disease. Gastroenterology 132, 2313-2319 (2007
100. Gradel K. O., et al. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 137, 495-501 (2009
101. Porter C. K., et al. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 135, 781-786 (2008
102. Garcia Rodriguez L. A., Ruigomez A. & Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 130, 1588-1594 (2006
103. Jess T., et al. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut 60, 318-324 (2011
104. Thompson N. P., et al. Is measles vaccination a risk factor for inflammatory bowel disease?. Lancet 345, 1071-1074 (1995
105. Bernstein C. N., Rawsthorne P. & Blanchard J. F. Population-based case-control study of measles mumps and rubella and inflammatory bowel disease. Inflamm. Bowel Dis. 13, 759-762 (2007
106. Davis R. L., et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch. Pediatr. Adolesc. Med. 155, 354-359 (2001
107. Cadwell K., et al. Virus plus susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135-1145 (2010
108. Ananthakrishnan A. N., Issa M. & Binion D. G. Clostridium difficile and inflammatory bowel disease. Gastroenterol. Clin. North Am. 38, 711-728 (2009
109. Singh S., Graff L. A. & Bernstein C. N. Do NSAIDs antibiotics infections or stress trigger flares in IBD?. Am. J. Gastroenterol. 104, 1298-1313 (2009
110. Penders J., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511-521 (2006
111. Shaw S. Y., Blanchard J. F. & Bernstein C. N. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am. J. Gastroenterol. 105, 2687-2692 (2010
112. Virta L., et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease-a nationwide register-based finnish case-control study. Am. J. Epidemiol. 175, 775-784 (2012
113. Shaw S. Y., Blanchard J. F. & Bernstein C. N. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am. J. Gastroenterol. 106, 2133-2142 (2011
114. Kronman M. P., et al. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130, e794-e803 (2012
115. Chan S. S., et al. Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study. Aliment. Pharmacol. Ther. 34, 649-655 (2011
116. Ananthakrishnan A. N., et al. Aspirin nonsteroidal anti-inflammatory drug use and risk for Crohn disease and ulcerative colitis: a cohort study. Ann. Intern. Med. 156, 350-359 (2012
117. Cornish J. A., et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am. J. Gastroenterol. 103, 2394-2400 (2008
118. Khalili H., et al. Oral contraceptives reproductive factors and risk of inflammatory bowel disease. Gut 62, 1153-1159 (2013
119. Khalili H., et al. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology 143, 1199-1206 (2012
120. Chapman-Kiddell C. A., Davies P. S., Gillen L. & Radford-Smith G. L. Role of diet in the development of inflammatory bowel disease. Inflamm. Bowel Dis. 16, 137-151 (2010
121. Hou J. K., Abraham B. & El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am. J. Gastroenterol. 106, 563-573 (2011
122. Amre D. K., et al. Imbalances in dietary consumption of fatty acids vegetables and fruits are associated with risk for Crohn's disease in children. Am. J. Gastroenterol. 102, 2016-2025 (2007
123. Ananthakrishnan A. N., et al. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 145, 970-977 (2013
124. Galvez J., Rodriguez-Cabezas M. E. & Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol. Nutr. Food Res. 49, 601-608 (2005
125. Roberts C. L., et al. Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 59, 1331-1339 (2010
126. Ananthakrishnan A. N., et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 63, 776-784 (2014
127. de Silva P. S., et al. An association between dietary arachidonic acid measured in adipose tissue and ulcerative colitis. Gastroenterology 139, 1912-1917 (2010
128. D'Souza S., et al. Dietary patterns and risk for Crohn's disease in children. Inflamm. Bowel Dis. 14, 367-373 (2008
129. Geerling B. J., et al. Diet as a risk factor for the development of ulcerative colitis. Am. J. Gastroenterol. 95, 1008-1013 (2000
130. Hart A. R., et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion 77, 57-64 (2008
131. John S., et al. Dietary n 3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur. J. Gastroenterol. Hepatol. 22, 602-606 (2010
132. Devkota S., et al. Dietary fat induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487, 104-108 (2012
133. Cabre E. & Domenech E. Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J. Gastroenterol. 18, 3814-3822 (2012
134. Costea I., et al. Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric Crohn's disease. Gastroenterology 146, 929-931 (2014
135. Jantchou P., et al. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am. J. Gastroenterol. 105, 2195-201 (2010
136. Chan S. S., et al. Carbohydrate intake in the etiology of Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. 20, 2013-2021 (2014
137. Zallot C., et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm. Bowel Dis. 19, 66-72 (2013
138. Cantorna M. T. & Mahon B. D. D hormone and the immune system. J. Rheumatol. Suppl. 76, 11-20 (2005
139. Cantorna M. T. & Mahon B. D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood) 229, 1136-1142 (2004
140. Cantorna M. T., et al. Vitamin D status 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 80, 1717S-1720S (2004
141. Cantorna M. T., et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130, 2648-2652 (2000
142. Froicu M. & Cantorna M. T. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 8, 5 (2007
143. Froicu M., et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17, 2386-2392 (2003
144. Froicu M., Zhu Y. & Cantorna M. T. Vitamin D receptor is required to control gastrointestinal immunity in IL 10 knockout mice. Immunology 117, 310-318 (2006
145. Mouli V. P. & Ananthakrishnan A. N. Review article: vitamin D and inflammatory bowel diseases. Aliment. Pharmacol. Ther. 39, 125-136 (2014
146. Ananthakrishnan A. N., et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 142, 482-489 (2012
147. Ananthakrishnan A. N., et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm. Bowel Dis. 19, 1921-1927 (2013
148. Cerasi M., Ammendola S. & Battistoni A. Competition for zinc binding in the host-pathogen interaction. Front. Cell. Infect. Microbiol. 3, 108 (2013
149. Haase H. & Rink L. Zinc signals and immune function. Biofactors 40, 27-40 (2014
150. Lahiri A. & Abraham C. Activation of pattern recognition receptors up-regulates metallothioneins thereby increasing intracellular accumulation of zinc autophagy and bacterial clearance by macrophages. Gastroenterology 147, 835-846 (2014
151. El-Tawil A. M. Zinc supplementation tightens leaky gut in Crohn's disease. Inflamm. Bowel Dis. 18, E399 (2012
152. Chua A. C., et al. Dietary iron enhances colonic inflammation and IL 6/IL 11-Stat3 signaling promoting colonic tumor development in mice. PLoS ONE 8, e78850 (2013
153. Carrier J., et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment. Pharmacol. Ther. 15, 1989-1999 (2001
154. Aamodt G., et al. The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway. Am. J. Epidemiol. 168, 1065-1072 (2008
155. Bernstein C. N., et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am. J. Gastroenterol. 105, 1994-2002 (2010
156. Bonaz B. L. & Bernstein C. N. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144, 36-49 (2013
157. Bailey M. T., et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav. Immun. 25, 397-407 (2011
158. Ghia J. E., et al. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 136, 2280-2288.e1-e4 (2009
159. Ananthakrishnan A. N., et al. Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. Clin. Gastroenterol. Hepatol. 11, 57-62 (2013
160. Bitton A., et al. Predicting relapse in Crohn's disease: a biopsychosocial model. Gut 57, 1386-1392 (2008
161. Goodhand J. & Rampton D. Psychological stress and coping in IBD. Gut 57, 1345-1347 (2008
162. Goodhand J. R., et al. Mood disorders in inflammatory bowel disease: relation to diagnosis disease activity perceived stress and other factors. Inflamm. Bowel Dis. 18, 2301-2309 (2012
163. Goodhand J. R., Wahed M. & Rampton D. S. Management of stress in inflammatory bowel disease: a therapeutic option?. Expert Rev. Gastroenterol. Hepatol. 3, 661-679 (2009
164. Lerebours E., et al. Stressful life events as a risk factor for inflammatory bowel disease onset: a population-based case-control study. Am. J. Gastroenterol. 102, 122-131 (2007
165. Levenstein S., et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am. J. Gastroenterol. 95, 1213-1220 (2000
166. Li J., et al. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Am. J. Gastroenterol. 99, 1129-1133 (2004
167. Maunder R. G. Evidence that stress contributes to inflammatory bowel disease: evaluation synthesis and future directions. Inflamm. Bowel Dis. 11, 600-608 (2005
168. Mawdsley J. E. & Rampton D. S. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54, 1481-1491 (2005
169. Rampton D. Does stress influence inflammatory bowel disease?. The clinical data. Dig. Dis. 27 (Suppl. 1), 76-79 (2009
170. Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut 31, 1037-1040 (1990
171. Cook M. D., et al. Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis. Brain Behav. Immun. 33, 46-56 (2013
172. Khalili H., et al. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ 347, f6633 (2013
173. Ananthakrishnan A. N., et al. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin. Gastroenterol. Hepatol. 11, 965-971 (2013
174. Kinnucan J. A., Rubin D. T. & Ali T. Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation. Gastroenterol. Hepatol. (N. Y.) 9, 718-727 (2013
175. Swanson G. R., Burgess H. J. & Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?. Expert Rev. Clin. Immunol. 7, 29-36 (2011
176. Ananthakrishnan A. N., et al. Sleep duration affects risk for ulcerative colitis: a prospective cohort study. Clin. Gastroenterol. Hepatol. 12, 1879-1886 (2014
177. Ali T., et al. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflamm. Bowel Dis. 19, 2440-2443 (2013
178. Cosnes J., et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 120, 1093-1099 (2001
179. Lunney P. C. & Leong R. W. Review article: Ulcerative colitis smoking and nicotine therapy. Aliment. Pharmacol. Ther. 36, 997-1008 (2012
180. Calabrese E., et al. Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J. Crohns Colitis 6, 756-762 (2012
181. Noh C. H., et al. Remission of ulcerative colitis after appendectomy: a case report [Korean]. Korean J. Gastroenterol. 56, 201-204 (2010
182. Okazaki K., et al. A patient with improvement of ulcerative colitis after appendectomy. Gastroenterology 119, 502-506 (2000
183. Tighe M. P., Cummings J. R. & Afzal N. A. Nutrition and inflammatory bowel disease: primary or adjuvant therapy. Curr. Opin. Clin. Nutr. Metab. Care 14, 491-496 (2011
184. D'Argenio V., et al. An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy. Am. J. Gastroenterol. 108, 851-852 (2013
185. Cohen S. A., et al. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 59, 516-521 (2014
186. Herfarth H. H., et al. Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm. Bowel Dis. 20, 1194-1197 (2014
187. Jorgensen S. P., et al. Clinical trial: vitamin D3 treatment in Crohn's disease-a randomized double-blind placebo-controlled study. Aliment. Pharmacol. Ther. 32, 377-383 (2010
188. Lev-Tzion R., et al. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews Issue 2. Art. No.: CD006320 http://dx.doi.org/10.1002/14651858.CD006320.pub4
189. Uchiyama K., et al. N 3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. Inflamm. Bowel Dis. 16, 1696-1707 (2010
190. Wahed M., et al. Does psychological counseling alter the natural history of inflammatory bowel disease?. Inflamm. Bowel Dis. 16, 664-669 (2010
191. Timmer A., et al. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews Issue 2. Art. No.: CD006913 http://dx.doi.org/10.1002/14651858.CD006913.pub2
192. Goodhand J. R., et al. Do antidepressants influence the disease course in inflammatory bowel disease?. A retrospective case-matched observational study. Inflamm. Bowel Dis. 18, 1232-1239 (2011
193. Wild C. P. Complementing the genome with an exposome: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 14, 1847-1850 (2005
194. Kanaly R. A., et al. Development of the adductome approach to detect DNA damage in humans. Antioxid. Redox Signal. 8, 993-1001 (2006
195. Bogdanos D. P., et al. Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun. Rev. 12, 726-740 (2013
196. Crohn's and Colitis Canada Inflammatory Bowel Disease GEM Project. The GEM project [online], www.gemproject.ca (2015
197. Connecticut Children's Medical Center. PROTECT [online], http://www.cscc.unc.edu/protect/(2015
198. PROKIIDS data centre. PRO-KIIDS Data Centre [online], https://prokiids.com (2015
199. Lomer M. C., et al. Efficacy and tolerability of a low microparticle diet in a double blind randomized pilot study in Crohn's disease. Eur. J. Gastroenterol. Hepatol. 13, 101-106 (2001
200. Lomer M. C., et al. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease. Eur. J. Gastroenterol. Hepatol. 17, 377-384 (2005
201. Turner D., Steinhart A. H. & Griffiths A. M. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews Issue 3. Art. No.: CD006443 http://dx.doi.org/10.1002/14651858.CD006443.pub2
202. Wright R. & Truelove S. C. A controlled therapeutic trial of various diets in ulcerative colitis. Br. Med. J. 2, 138-141 (1965
203. Ritchie J. K., et al. Controlled multicentre therapeutic trial of an unrefined carbohydrate fibre rich diet in Crohn's disease. Br. Med. J. (Clin. Res. Ed.) 295, 517-520 (1987
204. Bartel G., et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflamm. Bowel Dis. 14, 374-382 (2008
205. Chiba M., et al. Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet. World J. Gastroenterol. 16, 2484-2495 (2010
206. Zachos M., Tondeur M. & Griffiths A. M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews Issue 1. Art. No.: CD000542 http://dx.doi.org/10.1002/14651858.CD000542.pub2
207. Boye B., et al. INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease?. A randomized controlled trial. Inflamm. Bowel Dis. 17, 1863-1873 (2011